Management ChangeApr 20, 2026, 04:37 PM
Revium Rx. Appoints Amir Avraham as Permanent CEO
AI Summary
Revium Rx. announced the appointment of Mr. Amir Avraham as its permanent Chief Executive Officer, effective February 1, 2026. Mr. Avraham had previously served as interim CEO since May 22, 2025, and as a financial consultant since February 2024. His compensation package includes a monthly salary of NIS 55,000, eligibility for an annual discretionary cash bonus, and a one-time $50,000 bonus contingent on securing $5 million in new equity investments within 18 months. Additionally, he will receive options to purchase 1,300,000 shares.
Key Highlights
- Amir Avraham appointed permanent CEO, effective February 1, 2026.
- Monthly salary of NIS 55,000 (approximately $14,800 USD).
- Eligible for annual discretionary cash bonus.
- One-time $50,000 bonus for $5M equity investments within 18 months.
- Granted options to purchase 1,300,000 shares.